Related Experiment Video
Updated: Mar 27, 2026

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Kv10.1 K(+) channel: from physiology to cancer
Halima Ouadid-Ahidouch1,2, Ahmed Ahidouch3,4, Luis A Pardo5,6
1University of Picardie Jules Verne UFR of Sciences, EA4667 Laboratory of Cell and Molecular Physiology, SFR CAP-SANTE (FED 4231), Amiens, France. ha-sciences@u-picardie.fr.
Abstract:
K(+) ions play a major role in many cellular processes. The deregulation of K(+) signaling is associated with a variety of diseases including cancer. Ether-à-go-go-1 (Eag1, Kv10.1, KCNH1) is a member of the voltage-activated potassium channel family and was the first K(+) channel to be associated with oncogenesis and tumor development. Interestingly, in healthy tissue, Kv10.1 is only detected in the central nervous system, where it is involved in the regulation of excitability under repeated stimulation. Kv10.1 is in contrast robustly expressed in over 70 % human tumors, where its expression seems to be controlled by key regulators of proliferation and survival such as p53 and E2F1, often altered in cancer. Otherwise, Kv10.1 is involved in cell proliferation, survival, angiogenesis, migration, and invasion. This review aims to provide a comprehensive overview of the current status of research on the role of Kv10.1 channel in physiopathology. Focus is placed on biophysical and pharmacological properties of Kv10.1 channel, as well as its cycling, trafficking, and its role in the neuron and cancer. The possible mechanisms by which Kv10.1 channel affects tumor cell migration and survival in breast cancer and its regulation by extracellular proteins are discussed.
Insights
The Ether-à-go-go-1 (Kv10.1) potassium channel is crucial for cell functions and is highly expressed in human tumors, driving cancer development. Research explores Kv10.1
Area of Science:
- Molecular Biology
- Cell Physiology
- Oncology
Background:
- Potassium ions (K+) are vital for cellular processes, and their dysregulation is linked to diseases like cancer.
- Ether-à-go-go-1 (Eag1, Kv10.1, KCNH1) is a voltage-gated potassium channel implicated in oncogenesis.
- Kv10.1 is normally found in the central nervous system but is overexpressed in over 70% of human tumors.
Purpose of the Study:
- To provide a comprehensive review of Kv10.1 channel research in physiopathology.
- To examine the biophysical and pharmacological properties of Kv10.1.
- To elucidate the role of Kv10.1 in neuronal function and cancer.
Main Methods:
- Literature review of Kv10.1 channel research.
- Analysis of Kv10.1 expression in healthy and cancerous tissues.
- Investigation of Kv10.1's role in cell proliferation, survival, and migration.
Main Results:
- Kv10.1 expression is linked to cancer development and is regulated by cancer-associated genes like p53 and E2F1.
- Kv10.1 influences cell proliferation, survival, angiogenesis, migration, and invasion.
- The channel's role in breast cancer cell migration and survival, and its regulation by extracellular proteins, are discussed.
Conclusions:
- Kv10.1 is a significant factor in cancer development and progression.
- Understanding Kv10.1's mechanisms offers potential therapeutic targets for cancer treatment.
- Further research into Kv10.1's regulation and function is warranted.
More Related Videos
Related Concept Videos
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Non-gated Ion Channels
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells

